Donald E. Bobo Jr. - 03 May 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP,Strategy/Corp Development
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 03 May 2024
Net transactions value: -$336,987
Form type: 4
Filing time: 06 May 2024, 19:16:43 UTC
Previous filing: 08 Apr 2024
Next filing: 09 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	$40,744	-479	-1.2%	$85.06	39,289	03 May 2024	Direct
transaction	EW	Common Stock	Options Exercise	$0	+5,855	+15%	$0.000000	45,144	04 May 2024	Direct	F1
transaction	EW	Common Stock	Tax liability	$296,244	-3,475	-7.7%	$85.25	41,669	04 May 2024	Direct
holding	EW	Common Stock						38,615	03 May 2024	401(k)	F2
holding	EW	Common Stock						135,152	03 May 2024	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Performance Rights	Options Exercise	$0	-5,855	-100%	$0.000000^*	0	04 May 2024	Common Stock	5,855		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.
F2	Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Content

On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.

Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.